Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
As companies expand into new markets and regulations change, the volume of non-English cases is growing faster than English cases; consequently, translation requirements are rapidly expanding. Traditional translation processes are challenging to manage, necessitating manual tracking of documents as they pass from pharma to translation services and back. In addition, companies rarely have complete oversight of the documents or the translation service vendors employed by their affiliates. These services are typically slow, costly and have complex billing structures.
In stark contrast, Neural Machine Translation provides fast, validated, and auditable translations that can exceed human quality, factor in company specific needs, and even improve over time. Documents are processed regardless of size, with a transparent and predictable pricing structure.
This webinar will illustrate how a simple user interface allows intelligent, interactive case capture in multiple languages. Captured cases are translated into English, then automatically transferred into the database using a combination of Neural Machine Translation and Natural Language Processing.
Learn how automation and AI can help your organization address its translation challenges.
Practice Leader, Technology Solutions
IQVIA
As Practice Leader for the Technology Solutions business unit of IQVIA, Updesh Dosanjh is responsible developing the overarching strategy regarding Artificial Intelligence and Machine Learning as it relates to safety and pharmacovigilance. He is focused on the adoption of these innovative technologies and processes that will help optimize pharmacovigilance activities for better, faster results. Dosanjh has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition.
Over the course of his career, Dosanjh also worked with WCI, Logistics Consulting Partners, Amersys Systems Limited, and FJ Systems. Dosanjh holds a Bachelor’s degree in Materials Science from Manchester University and a Master’s degree in Advanced Manufacturing Systems and Technology from Liverpool University.
Head of Commercialization, IQVIA Translation Services
IQVIA
As Head of Commercialization, Gary Muddyman is responsible for the go to market strategy and its implementation for IQVIA Translation Services (IQT). Gary has been involved with IQT since its initiation in 2018.
Gary joined IQVIA after stepping down from Conversis, the leading translation business which he founded and led for 17 years. Conversis is known for advancing the understanding and use of localisation and translation as strategic business tools. Today, it provides a full range of technology, business and marketing products and services within more than 30 markets worldwide, and operates in the UK, Europe, and USA.
Gary currently advises the board of Red Dot Digital, an international digital marketing agency based in Toronto, Canada. Previously, he was vice-chairman of the Globalization and Localization Association (GALA) and served on the Advisory Boards of two industry charitable organisations, the Rosetta Foundation and Translators Without Borders. From 2012 to 2017 he was a contributor and advisor to the All-Party Parliamentary Group for modern languages in the UK which seeks to promote the development of policies to encourage quality language learning and use in the country.
Custom Content Writer
Informa Pharma Intelligence
